drug
DB-2Q
Phase 3updated 3mo agoby Direct Biologics LLC
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying DB-2Q
- phase3Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- phase2Study of ExoFlo for the Treatment of Perianal Fistulas
- phase1Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis
- phase1Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease
- —Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS
- —Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients
- phase2Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
- phase2Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 14m ago
Found something off?
comments(0)
5-min edit window · permanent after that